Steegen K - Search Results

1

Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings.

Steegen K, van Zyl GU, Claassen M, Khan A, Pillay M, Govender S, Bester PA, van Straaten JM, Kana V, Cutler E, Kalimashe MN, Lebelo RL, Moloi MBH, Hans L. Steegen K, et al. Diagnostics (Basel). 2023 Jun 29;13(13):2209. doi: 10.3390/diagnostics13132209. Diagnostics (Basel). 2023. PMID: 37443603 Free PMC article. Review.

2

Integration of clinical point-of-care requirements in a DNA microarray genotyping test.

Van Dorst B, Cremers A, Jans K, Van Domburg T, Steegen K, Huang C, Dorrer C, Lagae L, Ferwerda G, Stuyver LJ. Van Dorst B, et al. Among authors: steegen k. Biosens Bioelectron. 2014 Nov 15;61:605-11. doi: 10.1016/j.bios.2014.05.071. Epub 2014 Jun 11. Biosens Bioelectron. 2014. PMID: 24967749

3

HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.

Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Variava E, MacLeod W, Sanne I, Stevens WS, Carmona S. Steegen K, et al. J Antimicrob Chemother. 2017 Jan;72(1):210-219. doi: 10.1093/jac/dkw358. Epub 2016 Sep 22. J Antimicrob Chemother. 2017. PMID: 27659733

4

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.

Steegen K, Carmona S, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, MacLeod W, Sanne I, Stevens WS. Steegen K, et al. PLoS One. 2016 Dec 1;11(12):e0166305. doi: 10.1371/journal.pone.0166305. eCollection 2016. PLoS One. 2016. PMID: 27907009 Free PMC article.

5

Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.

Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Van Vuuren C, Macleod W, Sanne I, Stevens WS, Carmona SC. Steegen K, et al. J Infect Dis. 2016 Dec 15;214(12):1826-1830. doi: 10.1093/infdis/jiw491. Epub 2016 Oct 20. J Infect Dis. 2016. PMID: 27923946

6

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW. Rhee SY, et al. Among authors: steegen k. EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024. Epub 2017 Mar 19. EBioMedicine. 2017. PMID: 28365230 Free PMC article.

7

PhyloPi: An affordable, purpose built phylogenetic pipeline for the HIV drug resistance testing facility.

Bester PA, De Vries A, Riekert S, Steegen K, van Zyl G, Goedhals D. Bester PA, et al. Among authors: steegen k. PLoS One. 2019 Mar 5;14(3):e0213241. doi: 10.1371/journal.pone.0213241. eCollection 2019. PLoS One. 2019. PMID: 30835760 Free PMC article.

8

Resistance in patients failing integrase strand transfer inhibitors: a call to replace raltegravir with dolutegravir in third-line treatment in South Africa.

Steegen K, van Zyl G, Letsoalo E, Claassen M, Hans L, Carmona S. Steegen K, et al. Open Forum Infect Dis. 2019 Aug 21;6(10):ofz377. doi: 10.1093/ofid/ofz377. Online ahead of print. Open Forum Infect Dis. 2019. PMID: 31433056 Free PMC article.

9

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia.

Jordan MR, Hamunime N, Bikinesi L, Sawadogo S, Agolory S, Shiningavamwe AN, Negussie T, Fisher-Walker CL, Raizes EG, Mutenda N, Hunter CJ, Dean N, Steegen K, Kana V, Carmona S, Yang C, Tang AM, Parkin N, Hong SY. Jordan MR, et al. Among authors: steegen k. Medicine (Baltimore). 2020 Sep 11;99(37):e21661. doi: 10.1097/MD.0000000000021661. Medicine (Baltimore). 2020. PMID: 32925712 Free PMC article.

10

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa.

Steegen K, Moorhouse M, Wensing AM, Venter WD, Hans L. Steegen K, et al. J Int AIDS Soc. 2021 May;24(5):e25706. doi: 10.1002/jia2.25706. J Int AIDS Soc. 2021. PMID: 33943000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page